82 related articles for article (PubMed ID: 9644603)
1. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
Fukuda M; Kobayashi Y; Endo K; Kawai N; Tominaga K; Bessho M; Hirashima K
Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Fukuda M; Endo K; Takinami S; Kawai N; Tominaga K; Maesaki S; Bessho M; Yamazaki T
Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Urabe A; Fujita A; Aoki K; Koike M; Kitamura K; Ohbayashi Y; Oshimi K; Wakabayashi Y; Kuraishi Y; Kurihara I; Togawa A; Hoshino S; Ozawa K; Hotta T; Higashihara M; Nagoshi H; Hirai H; Omine M; Asano S; Nishimura M; Suzuki K; Bessho M; Mizoguchi H; Furusawa S; Nonaka Y; Takaku F
Jpn J Antibiot; 2000 Feb; 53(2):61-74. PubMed ID: 10786314
[TBL] [Abstract][Full Text] [Related]
4. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
5. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Matsushima T; Tamura K; Okamoto K; Kawada E; Murayama K; Maehara T; Sadakata H; Tamura J; Sawamura M; Morita K
Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
[TBL] [Abstract][Full Text] [Related]
6. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Takashima T; Tsuda S; Misawa S; Horiike S; Kuzuyama Y; Hirakawa K; Nakai H; Seriu T; Tanaka S; Nishida K
Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
Tanaka S; Tsuda S; Nakagawa H; Nishigaki H; Okuda T; Taniwaki M; Misawa S; Takino T; Abe T
Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefpirome sulfate for severe infections in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infections].
Hamazaki H; Hasegawa H; Horiuchi A; Teshima H; Hiraoka A; Masaoka T; Nasu K; Uchino H; Tatsumi N; Inoue N; Kageyama T; Kawagoe H; Tukaguchi M; Hukuhara S; Takahashi T; Takatsuka H; Kanamaru A; Kakishita E; Nagai K; Hara H; Kanayama Y; Sugiyama H; Kitani T
Jpn J Antibiot; 1997 Jan; 50(1):12-21. PubMed ID: 9059910
[TBL] [Abstract][Full Text] [Related]
9. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
Mizuno H; Yamao H; Saito H; Ohno R; Hotta T; Ohnishi K; Murate T; Kagami Y; Mitomo Y; Nitta M
Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of neutropenic fever associated with hematological disorders].
Fukuda M; Endo K; Ito K; Kawai N; Tominaga K; Bessho M; Hirasima K
Kansenshogaku Zasshi; 2001 Mar; 75(3):186-92. PubMed ID: 11321778
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
Hirakawa K; Tsuda S; Misawa S; Kuzuyama Y; Nakai H; Seriu T; Takashima T; Tanaka S; Nishigaki H; Yokota S
Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
[TBL] [Abstract][Full Text] [Related]
13. [Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
Chudanova TV; Abdulkadyrov KM; Chebotkevich VN
Antibiot Khimioter; 2003; 48(7):29-32. PubMed ID: 14628576
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Yamane T; Tanaka K; Hasuike T; Hirai M; Misu K; Ota K; Ohira H; Nakao Y; Yasui Y; Inoue T
Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Sasai Y; Iwai T; Tamura A; Nakazawa N; Ueda Y; Kaneko H; Horiike S; Yokota S; Taniwaki M; Kashima K; Misawa S; Tsuda S; Ohgawara Y
Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
Fukuda M; Hirashima K
Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of amikacin in the treatment of severe infections in a renal unit.
Alexopoulos E; Hadjidimitriou C; Anassis P; Papadimitriou M
Chemioterapia; 1987 Jun; 6(2 Suppl):386-9. PubMed ID: 3509454
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
Hotta T; Hirabayashi N; Shimizu K; Utsumi M; Katoh T; Maeda H; Hirano A; Ohnishi K; Murate T; Yamada H
Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
[TBL] [Abstract][Full Text] [Related]
20. [Combined clinical effect of amikacin and cefoxitin in patients with severe infections complicated by hematological diseases].
Uno N; Nosaka T; Uchiyama S; Kawakami K; Hoshino K; Mori M; Hotta Y; Ohta C; Kobayashi T; Kita K
Jpn J Antibiot; 1987 Mar; 40(3):469-75. PubMed ID: 3613072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
